HAMED KAMAL - Insider Non-Derivative Transactions at Spero Therapeutics, Inc. (SPRO) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Feb 2, 2024, HAMED KAMAL's relationship to Spero Therapeutics, Inc. (SPRO) is Officer (Chief Medical Officer), and currently has 788,117 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other SPRO insiders.

Data Source: SEC.
HAMED KAMAL - Insider Non-Derivative Transactions of SPRO Common Stock
HAMED KAMAL - Insider Non-Derivative Transactions at SPRO
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Feb 3, 2024 Sell -- (Common Stock) 28075 1.37 788117
Feb 2, 2024 Acquisition -- (Common Stock) 239731 0 816192
Sep 14, 2023 Sell -- (Common Stock) 39496 1.27 576461
Jun 13, 2023 Acquisition -- (Common Stock) 140000 0 615957
Feb 2, 2023 Acquisition -- (Common Stock) 265957 0 475957